The Role of Hypoxia-Inducible Factor Post-Translational Modifications in Regulating Its Localisation, Stability, and Activity
Open accessPublished version of a preprint
The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
The hypoxia signalling pathway enables adaptation of cells to decreased oxygen availability. When oxygen becomes limiting, the central transcription factors of the pathway, hypoxia-inducible factors (HIFs), are stabilised and activated to induce the expression of hypoxia-regulated genes, thereby maintaining cellular homeostasis. Whilst hydroxylation has been thoroughly described as the major and canonical modification of the HIF-α subunits, regulating both HIF stability and activity, a range of other post-translational modifications decorating the entire protein play also a crucial role in altering HIF localisation, stability, and activity. These modifications, their conservation throughout evolution, and their effects on HIF-dependent signalling are discussed in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Acetylation’s role in transcription goes further via mediating the stability of various transcription factors including HIF-1α [74] and p53 [75].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · cited 3×
“HIFs consists of an oxygen-dependent α subunit that is destabilised in normoxia and a constitutively expressed β subunit (HIF-1β or ARNT) [3,4].”
BackgroundJaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 2×
“Once hydroxylated, the HIF-α proteins are recognised by an E3-ligase complex containing the von-Hippel-Lindau protein (pVHL), which acts as the substrate recognition unit and, together with Cullin-2 (Cul-2), Elongin-1, Elongin-2 and Ring-Box 1 (RBX1), polyubiquitinates K532, K538 or K567 on HIF-1α (and K497, K503 or K…”
BackgroundCOSMIC: the Catalogue Of Somatic Mutations In Cancer
Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N., Boutselakis, H., Cole, C. G., Creatore, C., Dawson, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1015 · Cited by 4,867
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617 · cited 2×
“Three HIF-α subunits (HIF-1α, HIF-2α, HIF-3α) have been described, of which HIF-1α and HIF-2α are the best understood and considered as the major activators of hypoxia-induced gene transcription [2,5,6].”
BackgroundHuang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113 · cited 1×
“To achieve this, post-translational hydroxylation of two conserved proline residues (Pro-402/Pro-564 in HIF-1α; Pro-405/ Pro-531 in HIF-2α; P492 in HIF-3α) residing within an oxygen-dependent-degradation (ODD) domain is required [19,20,26,27].”
BackgroundPurification and Characterization of Hypoxia-inducible Factor 1
Wang, G. L., & Semenza, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1230 · Cited by 2,073 · cited 3×
“HIFs consists of an oxygen-dependent α subunit that is destabilised in normoxia and a constitutively expressed β subunit (HIF-1β or ARNT) [3,4].”
BackgroundATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
Blackford, A. N., & Jackson, S. P. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.015 · Cited by 1,961 · cited 1×
“Following the detection of DNA damage, p53, a potent tumour suppressor transcription factor, is stabilised via phosphorylation by ataxia telangiectasia mutated protein (pATM) [66].”
BackgroundThe history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767 · cited 1×
“Cyclindependent kinases (CDKs) belong to an important family of proteins involved in regulating and fine -tuning several stages of the cell cycle [56].”
BackgroundSalceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
Hornbeck, P. V., Kornhauser, J. M., Tkachev, S., Zhang, B., Skrzypek, E., Murray, B., Latham, V., & Sullivan, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1122 · Cited by 1,646 · cited 1×
“Phosphositeplus is a mass spectrometry data repository for PTM data [124].”
BackgroundOhh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577 · cited 1×
“Once hydroxylated, the HIF-α proteins are recognised by an E3-ligase complex containing the von-Hippel-Lindau protein (pVHL), which acts as the substrate recognition unit and, together with Cullin-2 (Cul-2), Elongin-1, Elongin-2 and Ring-Box 1 (RBX1), polyubiquitinates K532, K538 or K567 on HIF-1α (and K497, K503 or K…”
BackgroundLando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550 · cited 1×
“FIH is an asparaginyl hydroxylase and modifies HIF-1α and HIF-2α on their C-TAD residues N803 and N847, respectively [35,36].”
BackgroundMahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362 · cited 1×
“In mammals, two different isoforms have been identified: GSK-3α and GSK-3β, and despite their homology of 98% in their catalytical domain, their roles in metabolism are different [41-43].”
BackgroundBerra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg392 · Cited by 1,348 · cited 1×
“PHD2 acts as the main regulator of HIF-α degradation and has a key role in HIF-α intracellular dynamics [28,29].”
BackgroundLaughner, E., Taghavi, P., Chiles, K., Mahon, P. C., & Semenza, G. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3995-4004.2001 · Cited by 1,256 · cited 1×
“The participation of mTOR in the regulation of HIF-1α protein translation was also described [94].”
BackgroundHuang, L. E., Arany, Z., Livingston, D. M., & Bunn, H. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32253 · Cited by 1,190 · cited 1×
“The HIF-α proteins are destabilised in normoxia via the ubiquitin-proteasome pathway (Figure 1) [24,25].”
BackgroundTranscriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
Manalo, D. J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B. D., Ye, S. Q., Garcia, J. G. N., & Semenza, G. L. (2005) · Blood · doi:10.1182/blood-2004-07-2958 · Cited by 1,154 · cited 1×
“HIFs then recruit general co-activators such as CBP/p300 via the C-terminal transactivation domain (C-TAD), leading to the expression of more than ~300 genes [8,9].”
BackgroundGao, X., Wu, G., Gu, X., Fu, L., & Mei, C. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000355743 · Cited by 1,035
Integration of Oxygen Signaling at the Consensus HRE
Wenger, R. H., Stiehl, D. P., & Camenisch, G. (2005) · Science's STKE · doi:10.1126/stke.3062005re12 · Cited by 1,032 · cited 3×
“Consequently, HIF-α subunits accumulate in the nucleus, form a heterodimer with the constitutively expressed HIF-1β and bind to HREs [7].”
BackgroundEma, M., Taya, S., Yokotani, N., Sogawa, K., Matsuda, Y., & Fujii-Kuriyama, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4273 · Cited by 1,016 · cited 1×
“Three HIF-α subunits (HIF-1α, HIF-2α, HIF-3α) have been described, of which HIF-1α and HIF-2α are the best understood and considered as the major activators of hypoxia-induced gene transcription [2,5,6].”
BackgroundMasson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014
Semenza, G. L., Nejfelt, M. K., Chi, S. M., & Antonarakis, S. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5680 · Cited by 990 · cited 1×
“Hypoxia-inducible factors (HIFs), of which the first was described as a nuclear factor that enhances transcription of the erythropoietin (EPO) gene under hypoxic conditions by binding to a 3′ enhancer sequence element, are part of this pathway and maintain the adaptation at the transcriptional level [1,2].”
BackgroundTanimoto, K., Makino, Y., Pereira, T., & Poellinger, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4298 · Cited by 928 · cited 1×
“Once hydroxylated, the HIF-α proteins are recognised by an E3-ligase complex containing the von-Hippel-Lindau protein (pVHL), which acts as the substrate recognition unit and, together with Cullin-2 (Cul-2), Elongin-1, Elongin-2 and Ring-Box 1 (RBX1), polyubiquitinates K532, K538 or K567 on HIF-1α (and K497, K503 or K…”
BackgroundAn essential role for p300/CBP in the cellular response to hypoxia
Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F., & Livingston, D. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12969 · Cited by 790 · cited 1×
“HIFs then recruit general co-activators such as CBP/p300 via the C-terminal transactivation domain (C-TAD), leading to the expression of more than ~300 genes [8,9].”
BackgroundGu, Y.-Z., Moran, S. M., Hogenesch, J. B., Wartman, L. D., & Bradfield, C. A. (1998) · Europe PMC (PubMed Central) · Cited by 769
Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1α
Lim, J.-H., Lee, Y.-M., Chun, Y.-S., Chen, J., Kim, J.-E., & Park, J.-W. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.023 · Cited by 758 · cited 7×
“Promotes pVHL-mediated proteasomal degradation [101] Promotes pVHL-mediated proteasomal degradation [92] Promotes pVHL-mediated proteasomal degradation [28,29] Promotes pVHL-independent proteasomal degradation [49] Downregulates transcriptional activity [103] Increases protein stability and transcription of REDD1 [68]…”
BackgroundInfluentialRegulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation
Jeong, J.-W., Bae, M.-K., Ahn, M.-Y., Kim, S.-H., Sohn, T.-K., Bae, M.-H., Yoo, M.-A., Song, E. J., Lee, K.-J., & Kim, K.-W. (2002) · Cell · doi:10.1016/s0092-8674(02)01085-1 · Cited by 716
Kasprzak, K. S., Sunderman, F. W., & Salnikow, K. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2003.08.021 · Cited by 674
Land, S. C., & Tee, A. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611782200 · Cited by 507 · cited 10×
“During hypoxia, FIH activity is suppressed, allowing HIF-1α or -2α to complex with the CBP/p300 co-activators and increased transcriptional activation.”
BackgroundInfluentialRegulation of Hypoxia-Inducible Factor 2α Signaling by the Stress-Responsive Deacetylase Sirtuin 1
Dioum, E. M., Chen, R., Alexander, M. S., Zhang, Q., Hogg, R. T., Gerard, R. D., & Garcia, J. A. (2009) · Science · doi:10.1126/science.1169956 · Cited by 472
Regulation of HIF-1α Stability through S-Nitrosylation
Li, F., Sonveaux, P., Rabbani, Z. N., Liu, S., Yan, B., Huang, Q., Vujaskovic, Z., Dewhirst, M. W., & Li, C.-Y. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.024 · Cited by 437
BelAiba, R. S., Bonello, S., Zähringer, C., Schmidt, S., Hess, J., Kietzmann, T., & Görlach, A. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-04-0391 · Cited by 423
Self-citationMakino, Y., Kanopka, A., Wilson, W. J., Tanaka, H., & Poellinger, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200328200 · Cited by 375 · cited 1×
“HIF-3α mRNA is subject to alternative splicing in humans and in mice [14,15].”
BackgroundNF‐κB and HIF crosstalk in immune responses
D'Ignazio, L., Bandarra, D., & Rocha, S. (2016) · The FEBS Journal · doi:10.1111/febs.13578 · Cited by 363
HIF1A Employs CDK8-Mediator to Stimulate RNAPII Elongation in Response to Hypoxia
Galbraith, M. D., Allen, M. A., Bensard, C. L., Wang, X., Schwinn, M. K., Qin, B., Long, H. W., Daniels, D. L., Hahn, W. C., Dowell, R. D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.048 · Cited by 359 · cited 1×
“HIF-1α transcriptional activity has also shown evidence of positive regulation via kinases, but independent of their catalytic activity, whereby CDK8 is capable of associating with HIF-1α to induce RNA Polymerase II transcription [96].”
BackgroundInterdependent roles for hypoxia inducible factor and nuclear factor‐κB in hypoxic inflammation
Taylor, C. T. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.157669 · Cited by 354 · cited 1×
“Despite HIF-α transcriptional regulation not being the focus of this review, it is nevertheless important to highlight how such signalling crosstalks including JAK/STAT3 and NF-kB signalling have been associated with upregulation of HIF-1α at the transcriptional level [83-87].”
BackgroundLonati, E., Brambilla, A., Milani, C., Masserini, M., Palestini, P., & Bulbarelli, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00001 · Cited by 347 · cited 1×
“While PIN1 overexpression in cancer has been correlated with increased HIF-1α stability, the inverse is suggested to occur with AD whereby PIN1 promotes HIF-1α degradation via a GSK-3β-dependent mechanism [78,81].”
BackgroundThe post-translational modification, SUMOylation, and cancer (Review)
Han, Z.-J., Feng, Y.-H., Gu, B.-H., Li, Y.-M., & Chen, H. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4280 · Cited by 334 · cited 1×
“SUMO is comparable to ubiquitin in terms of its overall molecular structure and molecular weight yet can lead to distinct changes in a given protein regulation depending on the SUMO isoforms [109].”
BackgroundMottet, D., Dumont, V., Deccache, Y., Demazy, C., Ninane, N., Raes, M., & Michiels, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300763200 · Cited by 316 · cited 10×
“Given that GSK-3 phosphorylates various upstream and downstream targets of the PI3K/AKT/mTOR signalling pathways, its activity is subject to tight regulation.”
BackgroundInfluentialIncreased Prolyl 4-Hydroxylase Domain Proteins Compensate for Decreased Oxygen Levels
Stiehl, D. P., Wirthner, R., Köditz, J., Spielmann, P., Camenisch, G., & Wenger, R. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601719200 · Cited by 289 · cited 1×
“When cells are deprived of oxygen, PHDs have less molecular oxygen available to act as a co-factor, hence decreasing their activity and subsequent HIF-α hydroxylation [34].”
BackgroundMaynard, M. A., Qi, H., Chung, J., Lee, E. H. L., Kondo, Y., Hara, S., Conaway, R. C., Conaway, J. W., & Ohh, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208681200 · Cited by 283 · cited 1×
“To achieve this, post-translational hydroxylation of two conserved proline residues (Pro-402/Pro-564 in HIF-1α; Pro-405/ Pro-531 in HIF-2α; P492 in HIF-3α) residing within an oxygen-dependent-degradation (ODD) domain is required [19,20,26,27].”
BackgroundMylonis, I., Chachami, G., Samiotaki, M., Panayotou, G., Paraskeva, E., Kalousi, A., Georgatsou, E., Bonanou, S., & Simos, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605058200 · Cited by 266 · cited 7×
“Downregulates CRM1-dependent nuclear export [73,74] Blocks pVHL-mediated proteasomal degradation to enhance protein stability [57,58] Blocks proteasomal degradation to enhance protein stability [60] Promotes CBP/p300 co-activator recruitment [70] Promotes heterodimerisation with HIF-1β [79]”
BackgroundInfluentialmTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α
Cam, H., Easton, J. B., High, A., & Houghton, P. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.030 · Cited by 266 · cited 4×
“Given the fact 8265755311 17 70 15885 228 298 401 603 786 PAS-A PAS-B ODDD K532 K538 K567 S551 T555 S589 T498 T506 S510S505 S502 S576 S657 S668 S687 S692S641 S643 S247T63 T796 NTAD CTADHIF-1α S696 K709K19 K21K12 K11 K674 K32 K391 K477 8705424961 14 67 15484 230 300 404 568 830 PAS-A PAS-B ODDD NTAD CTADHIF-2α S383 T52…”
BackgroundInfluentialFlügel, D., Görlach, A., Michiels, C., & Kietzmann, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00015-07 · Cited by 258
Self-citationKoike, T., Kimura, N., Miyazaki, K., Yabuta, T., Kumamoto, K., Takenoshita, S., Chen, J., Kobayashi, M., Hosokawa, M., Taniguchi, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402088101 · Cited by 245 · cited 1×
“While several investigations suggest a link between glycosylation and hypoxia, it is still unclear whether and how HIF-α subunits are directly involved in these processes and whether they can themselves be targeted for glycosylation [117,118].”
BackgroundLi, J., Xu, Y., Long, X.-D., Wang, W., Jiao, H.-K., Mei, Z., Yin, Q.-Q., Ma, L.-N., Zhou, A.-W., Wang, L.-S., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.008 · Cited by 242 · cited 1×
“Further, the SUMO E3 ligase Cbx4 modifies HIF-1α at K391 and K477 to enhance HIF-1’s transcriptional activity [113].”
BackgroundMennerich, D., Kubaichuk, K., & Kietzmann, T. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.08.005 · Cited by 235 · cited 1×
“The action of DUBs on HIFs has been extensively and recently reviewed and will not be covered here [38,39].”
BackgroundSelf-citationSumoylation increases HIF-1α stability and its transcriptional activity
Bae, S.-H., Jeong, J.-W., Park, J. A., Kim, S.-H., Bae, M.-K., Choi, S.-J., & Kim, K.-W. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.068 · Cited by 232
Roles of the human hypoxia-inducible factor (HIF)-3α variants in the hypoxia response
Heikkilä, M., Pasanen, A., Kivirikko, K. I., & Myllyharju, J. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0679-5 · Cited by 213 · cited 1×
“The IPAS/HIF-1α complex was unable to bind to HREs and suggested to be a negative regulator of HIF-1α [15,16].”
BackgroundMethylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis
Kim, Y., Nam, H. J., Lee, J., Park, D. Y., Kim, C., Yu, Y. S., Kim, D., Park, S. W., Bhin, J., Hwang, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms10347 · Cited by 208 · cited 6×
“In line, LSD1 was then found to upregulate HIF-1α-dependent angiogenesis by increasing CBP, MTA1 and HIF1α binding to the VEGF promoter [100,101].”
BackgroundInfluentialmicroRNA-451: A conditional switch controlling glioma cell proliferation and migration
Godlewski, J., Bronisz, A., Nowicki, M. O., Chiocca, E. A., & Lawler, S. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12248 · Cited by 203
HDAC4 Protein Regulates HIF1α Protein Lysine Acetylation and Cancer Cell Response to Hypoxia
Geng, H., Harvey, C. T., Pittsenbarger, J., Liu, Q., Beer, T. M., Xue, C., & Qian, D. Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257055 · Cited by 197 · cited 2×
“HIF-1α protein stability by blocking non-pVHL-mediated proteasomal degradation [98].”
BackgroundInherent DNA‐binding specificities of the HIF‐1α and HIF‐2α transcription factors in chromatin
Smythies, J. A., Sun, M., Masson, N., Salama, R., Simpson, P. D., Murray, E., Neumann, V., Cockman, M. E., Choudhry, H., Ratcliffe, P. J., et al. (2019) · The EMBO Reports · doi:10.15252/embr.201846401 · Cited by 195
Flügel, D., Görlach, A., & Kietzmann, T. (2012) · Blood · doi:10.1182/blood-2011-08-375014 · Cited by 191
Self-citationHypoxia Inducible Factor-2α in Cancer
Löfstedt, T., Fredlund, E., Holmquist-Mengelbier, L., Pietras, A., Ovenberger, M., Poellinger, L., & Påhlman, S. (2007) · Cell Cycle · doi:10.4161/cc.6.8.4133 · Cited by 188
Hardman, G., Perkins, S., Brownridge, P. J., Clarke, C. J., Byrne, D. P., Campbell, A. E., Kalyuzhnyy, A., Myall, A., Eyers, P. A., Jones, A. R., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100847 · Cited by 161 · cited 1×
“Moreover, a recent investigation highlighted the existence of additional ‘non-canonical’ phosphorylatable residues within human cells, including histidine, arginine, lysine, aspartate, glutamate and cysteine [41].”
BackgroundHIF1α Protein Stability Is Increased by Acetylation at Lysine 709
Geng, H., Liu, Q., Xue, C., David, L. L., Beer, T. M., Thomas, G. V., Dai, M.-S., & Qian, D. Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.400697 · Cited by 157 · cited 2×
“The co-activator p300 also acetylates HIF-1α, at K709, to increase protein stability under hypoxia by suppressing its polyubiquitylation [96].”
BackgroundYasinska, I. M., & Sumbayev, V. V. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00807-x · Cited by 156 · cited 1×
“Initially, C800 S-nitrosylation was identified as a critical modification for CBP/p300 recruitment and transcriptional activation [115].”
BackgroundPasanen, A., Heikkilä, M. M., Rautavuoma, K., Hirsilä, M., Kivirikko, K. I., & Myllyharju, J. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.04.008 · Cited by 155 · cited 1×
“HIF-3α mRNA is subject to alternative splicing in humans and in mice [14,15].”
BackgroundLee, J.-Y., Park, J.-H., Choi, H.-J., Won, H.-Y., Joo, H., Shin, D.-H., Park, M. K., Han, B., Kim, K. P., Lee, T. J., et al. (2017) · Oncogene · doi:10.1038/onc.2017.158 · Cited by 147 · cited 10×
“The SET7/9-mediated methylation at K391 on HIF-1α induces protein destabilisation via the canonical PHD/VHL pathway [101].”
BackgroundInfluentialThe phosphorylation status of PAS‐B distinguishes HIF‐1α from HIF‐2α in NBS1 repression
To, K. K. W., Sedelnikova, O. A., Samons, M., Bonner, W. M., & Huang, E. L. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601369 · Cited by 143
Force, T., & Woodgett, J. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800077200 · Cited by 139 · cited 1×
“In mammals, two different isoforms have been identified: GSK-3α and GSK-3β, and despite their homology of 98% in their catalytical domain, their roles in metabolism are different [41-43].”
BackgroundSUMOylation of hypoxia-inducible factor-1α reduces its transcriptional activity
Berta, M., Mazure, N. M., Hattab, M., Pouysségur, J., & Brahimi-Horn, M. C. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.103 · Cited by 135
Menrad, H., Werno, C., Schmid, T., Copanaki, E., Deller, T., Dehne, N., & Brüne, B. (2010) · Hepatology · doi:10.1002/hep.23597 · Cited by 132
SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylation
Seo, K.-S., Park, J.-H., Heo, J. Y., Jing, K., Han, J., Min, K.-N., Kim, C., Koh, G. Y., Lim, K., Kang, G.-Y., et al. (2014) · Oncogene · doi:10.1038/onc.2014.76 · Cited by 131 · cited 1×
“This acetylation is antagonised and removed by SIRT2, which interacts directly to enhance the HIF-1α-PHD2 interaction [102].”
BackgroundBao, L., Chen, Y., Lai, H.-T., Wu, S.-Y., Wang, J. E., Hatanpaa, K. J., Raisanen, J. M., Fontenot, M., Lega, B., Chiang, C.-M., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky449 · Cited by 126 · cited 7×
“Promotes pVHL-mediated proteasomal degradation [101] Promotes pVHL-mediated proteasomal degradation [92] Promotes pVHL-mediated proteasomal degradation [28,29] Promotes pVHL-independent proteasomal degradation [49] Downregulates transcriptional activity [103] Increases protein stability and transcription of REDD1 [68]…”
BackgroundInfluentialThe Ubiquitin Ligase Siah2 and the Hypoxia Response
Nakayama, K., Qi, J., & Ronai, Z. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0458 · Cited by 122 · cited 1×
“Among the SIAH2 targets are PLK3 and PHD1/3 [52-54].”
BackgroundMakino, Y., Uenishi, R., Okamoto, K., Isoe, T., Hosono, O., Tanaka, H., Kanopka, A., Poellinger, L., Haneda, M., & Morimoto, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700732200 · Cited by 120 · cited 1×
“The IPAS/HIF-1α complex was unable to bind to HREs and suggested to be a negative regulator of HIF-1α [16,17].”
BackgroundIdentification of a functional antioxidant response element at the HIF1A locus
Lacher, S. E., Levings, D. C., Freeman, S., & Slattery, M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.08.014 · Cited by 119 · cited 1×
“ROS involve binding of nuclear factor erythroid 2-related factor 2 (NRF2) to an antioxidant response element (ARE) located approximately 30 kilobases upstream of the HIF1A transcriptional start [91,92].”
BackgroundA Nontranscriptional Role for HIF-1α as a Direct Inhibitor of DNA Replication
Hubbi, M. E., Kshitiz, Gilkes, D. M., Rey, S., Wong, C. C., Luo, W., Kim, D.-H., Dang, C. V., Levchenko, A., & Semenza, G. L. (2013) · Science Signaling · doi:10.1126/scisignal.2003417 · Cited by 116 · cited 1×
“HIF-1α has been shown to act as a negative regulator of DNA replication, exerting control over cell cycle progression [57].”
BackgroundA compendium of proteins that interact with HIF-1α
Semenza, G. L. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.041 · Cited by 115 · cited 1×
“Whilst there are many well-characterised binding partners and indirect regulators of HIF-1α and HIF-2α, PTMs constitute an essential direct regulatory mechanism for the HIF transcription factors [40].”
BackgroundHughes, K., Ramakrishna, S., Benjamin, W. B., & Woodgett, J. R. (1992) · Biochemical Journal · doi:10.1042/bj2880309 · Cited by 114
Hubbi, M. E., Gilkes, D. M., Hu, H., Kshitiz, Ahmed, I., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412840111 · Cited by 110
Bullen, J. W., Tchernyshyov, I., Holewinski, R. J., DeVine, L., Wu, F., Venkatraman, V., Kass, D. L., Cole, R. N., Van Eyk, J., & Semenza, G. L. (2016) · Science Signaling · doi:10.1126/scisignal.aaf0583 · Cited by 109 · cited 2×
“Inhibits oxygen-independent degradation to enhance protein stability [62] Promotes FBW7 E3 ligase-directed proteasomal degradation [44,46,47]”
BackgroundCDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth
Warfel, N. A., Dolloff, N. G., Dicker, D. T., Malysz, J., & El-Deiry, W. S. (2013) · Cell Cycle · doi:10.4161/cc.26930 · Cited by 108 · cited 2×
“Although this phosphorylation increased HIF's protein stability, the mechanisms appear to involve both the proteasome and/or lysosomal degradation of HIF-1α during the G1/S transition [57,58].”
BackgroundRepression of hypoxia-inducible factor α signaling by Set7-mediated methylation
Liu, X., Chen, Z., Xu, C., Leng, X., Cao, H., Ouyang, G., & Xiao, W. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv379 · Cited by 107 · cited 5×
“SET7/9, a monomethyl transferase known for its role in gene activation via modification of histone H3, has been found to also interact with HIF-1α and to methylate multiple sites [100-102].”
BackgroundInfluentialGradin, K., Takasaki, C., Fujii-Kuriyama, Y., & Sogawa, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201307200 · Cited by 105 · cited 4×
“Despite unsuccessful identification of the specific kinase responsible for this phosphorylation, CKII-like kinase was suggested to play a role, yet direct evidence has not yet been obtained [70-72].”
BackgroundInfluentialObacz, J., Pastoreková, S., Vojtesek, B., & Hrstka, R. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-93 · Cited by 105 · cited 1×
“Despite HIF-α transcriptional regulation not being the focus of this review, it is nevertheless important to highlight how such signalling crosstalks including JAK/STAT3 and NF-kB signalling have been associated with upregulation of HIF-1α at the transcriptional level [83-87].”
BackgroundXu, D., Yao, Y., Lu, L., Costa, M., & Dai, W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160325 · Cited by 100 · cited 5×
“Promotes pVHL-mediated proteasomal degradation [101] Promotes pVHL-mediated proteasomal degradation [92] Promotes pVHL-mediated proteasomal degradation [28,29] Promotes pVHL-independent proteasomal degradation [49] Downregulates transcriptional activity [103] Increases protein stability and transcription of REDD1 [68]…”
BackgroundInfluentialRole for casein kinase 2 in the regulation of HIF‐1 activity
Mottet, D., Ruys, S. P. D., Demazy, C., Raes, M., & Michiels, C. (2005) · International Journal of Cancer · doi:10.1002/ijc.21268 · Cited by 99 · cited 1×
“Despite unsuccessful identification of the specific kinase responsible for this phosphorylation, CKII-like kinase was suggested to play a role, yet direct evidence has not yet been obtained [71,74,75].”
BackgroundMylonis, I., Chachami, G., Paraskeva, E., & Simos, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803081200 · Cited by 96 · cited 7×
“Downregulates CRM1-dependent nuclear export [73,74] Blocks pVHL-mediated proteasomal degradation to enhance protein stability [57,58] Blocks proteasomal degradation to enhance protein stability [60] Promotes CBP/p300 co-activator recruitment [70] Promotes heterodimerisation with HIF-1β [79]”
BackgroundInfluentialRNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible Factor-2α
van Hagen, M., Overmeer, R. M., Abolvardi, S. S., & Vertegaal, A. C. O. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1157 · Cited by 92 · cited 15×
“The functional outcome of HIF-1α SUMOylation remains unclear due to controversy between investigations.”
BackgroundInfluentialRyu, J.-H., Li, S.-H., Park, H.-S., Park, J.-W., Lee, B., & Chun, Y.-S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188706 · Cited by 90 · cited 1×
“NEDD8 stabilised HIF-1α under both normoxia and hypoxia in VHL deficient cells, suggesting a VHL-independent process [122].”
BackgroundPin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease
Driver, J. A., Zhou, X. Z., & Lu, K. P. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.12.025 · Cited by 88 · cited 1×
“Interestingly, an inverse association has been noted between cancer and Alzheimer’s Disease (AD) concerning PIN1 regulation of HIF-1α [80].”
BackgroundCasein kinase 1 regulates human hypoxia-inducible factor HIF-1
Kalousi, A., Mylonis, I., Politou, A. S., Chachami, G., Paraskeva, E., & Simos, G. (2010) · Journal of Cell Science · doi:10.1242/jcs.068122 · Cited by 88 · cited 4×
“Furthermore, HIF-2α nuclear localisation is also dependent on additional modification at S383 and T528 by CK1δ, which assists indirectly to the CRM1-dependent mechanism, by facilitating nuclear retention likely via binding to immobile nuclear (or chromatin) components [81].”
BackgroundInfluentialNegative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxia
Cassavaugh, J. M., Hale, S. A., Wellman, T. L., Howe, A. K., Wong, C., & Lounsbury, K. M. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23321 · Cited by 88 · cited 9×
“This could be antagonised by the DUB ubiquitin-specific protease 28 (USP28) [46,47].”
BackgroundInfluentialWatanabe, Y., Murdoch, C. E., Sano, S., Ido, Y., Bachschmid, M. M., Cohen, R. A., & Matsui, R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524198113 · Cited by 87 · cited 2×
“Changes in oxidised glutathione can modulate HIF signalling via S-glutathionylation of target cysteines in human oral squamous cell carcinoma cells, and in C2C12 mouse myoblasts [115-117].”
BackgroundLANCASTER, D. E., McNEILL, L. A., McDONOUGH, M. A., APLIN, R. T., HEWITSON, K. S., PUGH, C. W., RATCLIFFE, P. J., & SCHOFIELD, C. J. (2004) · Biochemical Journal · doi:10.1042/bj20040735 · Cited by 86 · cited 1×
“Interestingly, this T796 phosphorylation may also abrogate the HIF-1α/FIH interaction to enhance HIF-1 transcriptional activity [72,73].”
BackgroundInteraction between HIF‐1α (ODD) and hARD1 does not induce acetylation and destabilization of HIF‐1α
Arnesen, T., Kong, X., Evjenth, R., Gromyko, D., Varhaug, J. E., Lin, Z., Sang, N., Caro, J., & Lillehaug, J. R. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.10.036 · Cited by 86
Modeling the interplay between the HIF-1 and p53 pathways in hypoxia
Zhou, C., Zhang, X., Liu, F., & Wang, W. (2015) · Scientific Reports · doi:10.1038/srep13834 · Cited by 84 · cited 1×
“p53 and HIF-1α display extensive crosstalk to balance survival and proapoptotic signalling, in response to severe hypoxia or anoxia [67,68].”
BackgroundPIASy stimulates HIF1α SUMOylation and negatively regulates HIF1α activity in response to hypoxia
Kang, X., Li, J., Zou, Y., Yi, J., Zhang, H., Cao, M., Yeh, E. T. H., & Cheng, J. (2010) · Oncogene · doi:10.1038/onc.2010.297 · Cited by 82
Toffoli, S., Féron, O., Raes, M. J., & Michiels, C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.06.002 · Cited by 78
Regulators and Effectors of Siah Ubiquitin Ligases
Qi, J., Kim, H., Scortegagna, M., & Ronai, Z. A. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9636-2 · Cited by 74 · cited 1×
“Among the SIAH2 targets are PLK3 and PHD1/3 [52-54].”
BackgroundBagnall, J., Leedale, J., Taylor, S. E., Spiller, D. G., White, M. R. H., Sharkey, K. J., Bearon, R. N., & Sée, V. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.500405 · Cited by 74 · cited 3×
“Promotes pVHL-mediated proteasomal degradation [101] Promotes pVHL-mediated proteasomal degradation [92] Promotes pVHL-mediated proteasomal degradation [28,29] Promotes pVHL-independent proteasomal degradation [49] Downregulates transcriptional activity [103] Increases protein stability and transcription of REDD1 [68]…”
BackgroundSelf-citationUbiquitin, SUMO, and NEDD8: Key Targets of Bacterial Pathogens
Ribet, D., & Cossart, P. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.07.005 · Cited by 70 · cited 1×
“Common PTMs to a target protein include phosphorylation, acetylation, methylation, and alkylation as well as the covalent linkage of fatty acids, saccharides or small proteins such as ubiquitin and SUMO (small ubiquitin-related modifier) [22].”
BackgroundThe redox state of glutathione regulates the hypoxic induction of HIF-1
Tajima, M., Kurashima, Y., Sugiyama, K., Ogura, T., & Sakagami, H. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.01.026 · Cited by 68 · cited 1×
“Changes in oxidised glutathione can modulate HIF signalling via S-glutathionylation of target cysteines in human oral squamous cell carcinoma cells, and in C2C12 mouse myoblasts [115-117].”
BackgroundRegulation of HIF-1α at the Transcriptional Level
Gorlach, A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649420 · Cited by 67
Modeling the regulation of p53 activation by HIF‐1 upon hypoxia
Wang, P., Guan, D., Zhang, X., Liu, F., & Wang, W. (2019) · FEBS Letters · doi:10.1002/1873-3468.13525 · Cited by 65 · cited 1×
“p53 and HIF-1α display extensive crosstalk to balance survival and proapoptotic signalling, in response to severe hypoxia or anoxia [67,68].”
BackgroundRegulation of PTEN Stability and Activity by Plk3
Xu, D., Yao, Y., Jiang, X., Lu, L., & Dai, W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166462 · Cited by 64 · cited 1×
“The role of PLK3 in regulating cell survival and proliferation in vivo has been further demonstrated by the same group, via PLK3-dependent phosphorylation of PTEN to enhance PTEN protein stability [51].”
BackgroundTolonen, J.-P., Heikkilä, M., Malinen, M., Lee, H.-M., Palvimo, J. J., Wei, G.-H., & Myllyharju, J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03387-9 · Cited by 63 · cited 1×
“By contrast, the long human splice variant HIF-3α2 induces expression of various genes among them the EPO gene [18].”
BackgroundHubert, A., Paris, S., Piret, J.-P., Ninane, N., Raes, M., & Michiels, C. (2006) · Journal of Cell Science · doi:10.1242/jcs.03069 · Cited by 62 · cited 1×
“Despite unsuccessful identification of the specific kinase responsible for this phosphorylation, CKII-like kinase was suggested to play a role, yet direct evidence has not yet been obtained [71,74,75].”
BackgroundVollmer, S., Kappler, V., Kaczor, J., Flügel, D., Rolvering, C., Kato, N., Kietzmann, T., Behrmann, I., & Haan, C. (2009) · Hepatology · doi:10.1002/hep.22928 · Cited by 61
Self-citationCho, H., Ahn, D.-R., Park, H., & Yang, E. G. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.015 · Cited by 57 · cited 2×
“However, a later investigation found that incorporation of the polar NO group potentially disrupted this interaction with the result that C800 S-nitrosylation suppressed CBP/p300 recruitment [73].”
BackgroundPaltoglou, S., & Roberts, B. J. (2007) · Oncogene · doi:10.1038/sj.onc.1209818 · Cited by 55 · cited 1×
“Once hydroxylated, the HIF-α proteins are recognised by an E3-ligase complex containing the von-Hippel-Lindau protein (pVHL), which acts as the substrate recognition unit and, together with Cullin-2 (Cul-2), Elongin-1, Elongin-2 and Ring-Box 1 (RBX1), polyubiquitinates K532, K538 or K567 on HIF-1α (and K497, K503 or K…”
BackgroundHerzog, J., Ehrlich, S. M., Pfitzer, L., Liebl, J., Fröhlich, T., Arnold, G. J., Mikulits, W., Haider, C., Vollmar, A. M., & Zahler, S. (2016) · Oncotarget · doi:10.18632/oncotarget.8342 · Cited by 53 · cited 1×
“Furthermore, CDK5, which is distinct from the other CDKs as it does not involve a cyclin subunit for catalytic activation, modifies HIF-1α at S687 and increases its stability [61].”
BackgroundOusset, M., Bouquet, F., Fallone, F., Biard, D., Dray, C., Valet, P., Salles, B., & Muller, C. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12253 · Cited by 51 · cited 1×
“In contradiction to this activatory role of pATM on HIF-1α, others have found that loss of pATM positively regulates the transcription and translation of HIF-1 (α and β) proteins through oxidative stress [70].”
BackgroundMechanisms of c-Myc Degradation by Nickel Compounds and Hypoxia
Li, Q., Kluz, T. S., Sun, H., & Costa, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008531 · Cited by 49 · cited 2×
“In addition, CDK2 positively regulates HIF-1α transactivity in cancer cells, and it was postulated that CDK2 could uncouple the transcriptional and non-transcriptional functions of HIF-1α in a manner analogous to the well-characterised mechanism involving cMYC and SKP2 [58,60].”
BackgroundPapadakis, A. I., Paraskeva, E., Peidis, P., Muaddi, H., Li, S., Raptis, L., Pantopoulos, K., Simos, G., & Koromilas, A. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0215 · Cited by 47
Daly, L. A., Brownridge, P. J., Batie, M., Rocha, S., Sée, V., & Eyers, C. E. (2021) · Science Signaling · doi:10.1126/scisignal.abf6685 · Cited by 44
Self-citationGkotinakou, I.-M., Befani, C., Simos, G., & Liakos, P. (2019) · Journal of Cell Science · doi:10.1242/jcs.225698 · Cited by 43 · cited 3×
“Much like HIF-1α, HIF-2α nuclear localisation is regulated by ERK1/2 phosphorylation at S672 [80].”
BackgroundNonaka, M., Fukuda, M. N., Gao, C., Li, Z., Zhang, H., Greene, M. I., Peehl, D. M., Feizi, T., & Fukuda, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559047 · Cited by 38 · cited 1×
“While several investigations suggest a link between glycosylation and hypoxia, it is still unclear whether and how HIF-α subunits are directly involved in these processes and whether they can themselves be targeted for glycosylation [117,118].”
BackgroundHIF-2α phosphorylation by CK1δ promotes erythropoietin secretion in liver cancer cells under hypoxia
Pangou, E., Befani, C., Mylonis, I., Samiotaki, M., Panayotou, G., Simos, G., & Liakos, P. (2016) · Journal of Cell Science · doi:10.1242/jcs.191395 · Cited by 37
Lucia, K. E., Wu, Y., Garcia, J. L. M., Barlier, A., Buchfelder, M., Saeger, W., Renner, U., Stalla, G. K., & Theodoropoulou, M. (2020) · Oncogene · doi:10.1038/s41388-020-1223-6 · Cited by 37 · cited 1×
“A recent study identified a feedback mechanism where hypoxia activates PKA via HIF-1α mediated suppression of the PKA regulatory subunit 2B (PRKAR2B) transcription, by sequestering SP1 from the PRKAR2B promoter [65].”
BackgroundPeptidyl Prolyl Isomerase PIN1 Directly Binds to and Stabilizes Hypoxia-Inducible Factor-1α
Han, H., Kwon, N., Choi, M., Jung, K. O., Piao, J., Ngo, H. K. C., Kim, S., Kim, D., Chung, J., Cha, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147038 · Cited by 36 · cited 2×
“Either S641 and S643 phosphorylation constitutes a PIN1 consensus motif (pSerPro), whereby PIN1, a peptidyl-prolyl cis/trans isomerase overexpressed in several human cancers, induces a conformational change in HIF-1α to increase protein stability and transcriptional activity in an ERK1/2-dependent manner [78,79].”
BackgroundTaylor, S. E., Bagnall, J., Mason, D. Y., Lévy, R., Fernig, D. G., & Sée, V. (2016) · Open Biology · doi:10.1098/rsob.160195 · Cited by 34 · cited 1×
“localisation and intranuclear diffusion speed [10].”
Self-citationFIH permits NAA10 to catalyze the oxygen-dependent lysyl-acetylation of HIF-1α
Kang, J., Chun, Y., Huh, J., & Park, J. (2018) · Redox Biology · doi:10.1016/j.redox.2018.09.002 · Cited by 34 · cited 1×
“Recent evidence suggests that FIH is required to directly modify hARD1/NAA10, at W38, during normoxia (utilising molecular oxygen as a cofactor) to activate its lysine acetyltransferase activity, thereby facilitating HIF-1α acetylation [100].”
Backgroundal Taleb, Z., Petry, A., Chi, T. F., Mennerich, D., Görlach, A., Dimova, E. Y., & Kietzmann, T. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1439-7 · Cited by 33 · cited 2×
“ROS involve binding of nuclear factor erythroid 2-related factor 2 (NRF2) to an antioxidant response element (ARE) located approximately 30 kilobases upstream of the HIF1A transcriptional start [91,92].”
BackgroundSelf-citationDu, S.-C., Zhu, L., Wang, Y.-X., Liu, J., Zhang, D., Chen, Y.-L., Peng, Q., Liu, W., & Liu, B. (2019) · Cancer Cell International · doi:10.1186/s12935-018-0722-9 · Cited by 32 · cited 7×
“Furthermore, this investigation also highlighted that the SUMO-protease SENP1, which has shown action against HIF-1α, is also capable to recognise and regulate HIF-2α.”
BackgroundInfluentialCannito, S., Foglia, B., Villano, G., Turato, C., Delgado, T. C., Morello, E., Pin, F., Novo, E., Napione, L., Quarta, S., et al. (2019) · Cancers · doi:10.3390/cancers11121933 · Cited by 32 · cited 1×
“More recently it was reported that SerpinB3 (SB3), a hypoxia and HIF-2α-dependent cysteineprotease inhibitor, can directly neddylate and stabilise HIF-2α, which led to an upregulation of its target genes in liver cancer cells [119].”
BackgroundLi, C., Park, S., Zhang, X., Dai, W. H., & Xu, D. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.767178 · Cited by 25 · cited 4×
“When cells are deprived of oxygen, PHDs have less molecular oxygen available to act as a co-factor, hence decreasing their activity and subsequent HIF-α hydroxylation [33].”
BackgroundInfluentialThe prolyl isomerase Pin1 regulates hypoxia-inducible transcription factor (HIF) activity
Jalouli, M., Déry, M.-A. C., Lafleur, V. N., Lamalice, L., Zhou, X. Z., Lu, K. P., & Richard, D. E. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.005 · Cited by 21 · cited 2×
“Either S641 and S643 phosphorylation constitutes a PIN1 consensus motif (pSerPro), whereby PIN1, a peptidyl-prolyl cis/trans isomerase overexpressed in several human cancers, induces a conformational change in HIF-1α to increase protein stability and transcriptional activity in an ERK1/2-dependent manner [78,79].”
BackgroundDUBs, New Members in the Hypoxia Signaling clUb
Schober, A. S., & Berra, E. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00053 · Cited by 21 · cited 1×
“The action of DUBs on HIFs has been extensively and recently reviewed and will not be covered here [38,39].”
BackgroundJeon, D., Park, H. J., & Kim, H. S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.018 · Cited by 21
Asparagine Hydroxylation is a Reversible Post-translational Modification
Rodríguez, J., Haydinger, C. D., Peet, D. J., Nguyen, L. K., & von Kriegsheim, A. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002189 · Cited by 21 · cited 1×
“HIF-α hydroxylation has long been considered to be an irreversible PTM, but it was recently shown, by mass spectrometry, that the FIH-mediated asparagine hydroxylation is indeed a reversible process [37].”
BackgroundAsparagine hydroxylation is likely to be a reversible post-translational modificationPreprint
Rodríguez, J., Haydinger, C. D., Peet, D. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.22.002436 · Cited by 4
Daly, L. A., Brownridge, P., Sée, V., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.12.379768 · Cited by 4 · cited 13×
“Interestingly, of these 6 phosphorylation sites, S31 has recently been evidenced in a separate study, to abrogate HIF-1α-dependent transcription without impacting protein stability; opening up avenues of direct transcriptional regulation of HIF by PTM and potentially delineating the consensus that HIF-α stability resu…”
BackgroundInfluentialSelf-citation(2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403922101 · Cited by 2
Research works printed but not linked: 1
- Vollmer, 2010, Hypoxia-inducible factor 1 alpha is upregulated by oncostatin M and participates in oncostatin M signalling, Eur. J. Cell Biol., 89, 6
Cited by
The effect of HIF on metabolism and immunity
Taylor, C. T., & Scholz, C. C. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00587-8 · Cited by 517
Cardiac metabolism in HFpEF: from fuel to signalling
Capone, F., Sotomayor-Flores, C., Bode, D., Wang, R., Rodolico, D., Strocchi, S., & Schiattarella, G. G. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac166 · Cited by 154
Transcriptional Response to Hypoxia: The Role of HIF-1-Associated Co-Regulators
Yfantis, A., Mylonis, I., Chachami, G., Nikolaidis, M., Amoutzias, G. D., Paraskeva, E., & Simos, G. (2023) · Cells · doi:10.3390/cells12050798 · Cited by 155
Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy
Sun, S., Ding, Z., Yang, X., Zhao, X., Zhao, M., Gao, L., Chen, Q., Xie, S., Liu, A., Yin, S., et al. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s297631 · Cited by 145
The ubiquitin codes in cellular stress responses
Sheng, X., Xia, Z., Yang, H., & Hu, R. (2023) · Protein & Cell · doi:10.1093/procel/pwad045 · Cited by 129
“Three HIF-α proteins (HIF-1 α , HIF-2 α , and HIF-3 α ) are Class 1 bHLH-PAS proteins, which can heterodimer-ize with Class 2 bHLH-PAS protein HIF-1 β (ARNT) or tissue-specific expressed HIF-2 β (ARNT2), via their basic bHLH-PAS domains (Wu and Rastinejad 2017; Albanese et al. 2020).”
Background
Metadata
- Authors
- Albanese, A., Daly, L. A., Mennerich, D., Kietzmann, T., & Sée, V.
- Affiliations
- University of Liverpool (GB)
- University of Oulu (FI)
- Corresponding author
- Sée, Violaine
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-12-29
- Volume
- 22
- Issue
- 1
- Pages
- 268
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7796330
- OpenAlex
- W3109826407
- Cited by
- 136
- References
- 131
- Citations by year
- 2026: 24 · 2025: 26 · 2024: 18 · 2023: 24 · 2022: 30 · 2021: 11 · 2020: 1
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Academy of Finland (SA296027)
- MRC (DiMen studentship)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- hypoxia-inducible factor, post-translational modification, protein stability, protein localization, hypoxia signaling, oxygen sensing, hydroxylation
- MeSH terms
- Animals, Hypoxia, Humans, Protein Processing, Post-Translational, Signal Transduction, Biomarkers, Protein Transport, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit, Ubiquitination, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.